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Background: The second messenger cyclic diguanylate (c-di-GMP) plays a central role in bacterial adaptation to
extracellular stimuli, controlling processes such as motility, biofilm development, cell development and, in some
pathogens, virulence. The intracellular level of c-di-GMP is controlled by the complementary activities of diguanylate
cyclases containing a GGDEF domain and two classes of c-di-GMP phosphodiesterases containing an EAL or HD-GYP
hydrolytic domain. Compared to the GGDEF and EAL domains, the functions of HD-GYP domain family proteins are
poorly characterized. The human diarrheal pathogen Vibrio cholerae encodes nine putative HD-GYP domain proteins.
To determine the contributions of HD-GYP domain proteins to c-di-GMP signaling in V. cholerae, we systematically
analyzed the enzymatic functionality of each protein and their involvement in processes known to be regulated by
c-di-GMP: motility, biofilm development and virulence.
Results: Complementary in vitro and in vivo experiments showed that four HD-GYP domain proteins are active c-di-GMP
phosphodiesterases: VC1295, VC1348, VCA0210 and VCA0681. Mutation of individual HD-GYP domain genes, as well as
combinatorial mutations of multiple HD-GYP domain genes, had no effect on motility or biofilm formation of V. cholerae
under the conditions tested. Furthermore, no single HD-GYP domain gene affected intestinal colonization by V. cholerae
in an infant mouse model. However, inactivation of multiple HD-GYP domain genes, including the four encoding
functional phosphodiesterases, significantly attenuated colonization.
Conclusions: These results indicate that the HD-GYP family of c-di-GMP phosphodiesterases impacts signaling by
this second messenger during infection. Altogether, this work greatly furthers the understanding of this important
family of c-di-GMP metabolic enzymes and demonstrates a role for HD-GYP domain proteins in the virulence of
V. cholerae.
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Cyclic diguanylate (c-di-GMP) is a bacterial second
messenger first identified as an activator of cellulose
synthesis in Gluconacetobacter xylinus [1]. Since its
discovery, the number of processes known to be regu-
lated by c-di-GMP in bacteria has expanded. c-di-
GMP signaling has been shown to regulate numerous
processes including, but not limited to, motility and bio-
film production in numerous bacterial species (reviewed* Correspondence: rtamayo@med.unc.edu
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unless otherwise stated.in [2-4]). In certain pathogens, c-di-GMP also influences
virulence properties [5-17].
The concentration of c-di-GMP is controlled by the
competing actions of two classes of enzymes: diguanylate
cyclases, which are responsible for the synthesis of c-di-
GMP from two molecules of GTP, and phosphodiester-
ases, which hydrolyze c-di-GMP forming two molecules
of GMP. Diguanylate cyclase activity has been demon-
strated in proteins containing GGDEF domains, and
c-di-GMP phosphodiesterase activity has been observed
in two unrelated protein domains, the EAL and HD-
GYP domains [18-24]. EAL domain phosphodiesterases
were the first to be described and have been more exten-
sively studied in terms of structure and biochemical andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
McKee et al. BMC Microbiology 2014, 14:272 Page 2 of 13
http://www.biomedcentral.com/1471-2180/14/272biological function. Comparatively little is known about
the functions of HD-GYP domain proteins.
The first protein containing an HD-GYP domain shown
to act as a c-di-GMP phosphodiesterase was RpfG from
plant pathogenic Xanthomonas spp. [21]. RpfG is a re-
sponse regulator containing a phosphoreceiver (REC)
domain and an HD-GYP domain. Along with the sensor
histidine kinase RpfC, RpfG responds to extracellular
diffusible signal factor (DSF), a cell-to-cell signaling factor.
Evidence suggests that, in response to DSF, RpfC
phosphorylates the REC domain of RpfG, triggering
the phosphodiesterase activity of the HD-GYP domain
[25,26]. The consequent decrease in intracellular c-di-
GMP leads to derepression of Clp, a transcription
factor inhibited by binding of c-di-GMP, activating
transcription of genes necessary for virulence factor
production [27-30]. Deletion of rpfG or amino acid
substitutions in conserved residues of the HD-GYP
domain, both of which abrogate c-di-GMP hydrolysis,
resulted in decreased virulence factor secretion, and
virulence factor secretion was restored in bacteria comple-
mented with an EAL domain phosphodiesterase, indicat-
ing that c-di-GMP hydrolysis by RpfG is responsible for
this phenotype [21,25,31,32].
In Pseudomonas aeruginosa, two genes encoding HD-
GYP domains, PA4108 and PA4781, are necessary for
full virulence in the Greater wax moth Galleria mello-
nella and for optimal swarming motility [33-35]. The
HD-GYP phosphodiesterase PdeB of Borrelia burgdorferi
plays a role in motility and contributes to survival of the
bacterium in the tick vector Ixodes scapularis and to
transmission of the bacterium to mice [13,36].
The genome of the human diarrheal pathogen Vibrio
cholerae contains numerous genes encoding confirmed
or putative c-di-GMP metabolic enzymes: 31 genes encod-
ing GGDEF domains, 12 genes encoding EAL domains, 10
genes encoding tandem GGDEF-EAL genes, and 9 genes
encoding HD-GYP domains [37,38]. A handful of diguany-
late cyclases and EAL domain phosphodiesterase enzymes
have been shown to impact motility, biofilm formation and
virulence in animal models [14,15,39-46]. HD-GYP domain
phosphodiesterases similarly have the potential to impact
motility, biofilm formation and virulence of V. cholerae
through modulation of c-di-GMP. However, relatively little
is known about the function(s) of HD-GYP domain pro-
teins in V. cholerae. The expression of four of these genes
(VC2340, VCA0210, VCA0681, VCA0895) was upregulated
in the presence of the quorum sensing autoinducers [47].
Ectopic over-expression of VCA0681 resulted in a re-
duced intracellular c-di-GMP concentration, indicating
that VCA0681 possesses c-di-GMP phosphodiesterase
activity [47]. Mutation of either VCA0681 or VCA0895
had no effect on biofilm formation in that study. Re-
cently, bile acids, an extracellular signal encountered byV. cholerae in the intestine, were shown to activate and re-
press expression of the HD-GYP domain genes VC2497
and VC1295, respectively [48]. Furthermore, a VC1295
mutant has somewhat increased c-di-GMP and biofilm
formation in the presence of bile acids, consistent with
PDE function [48]. Beyond these experiments, not much
is known about the function of HD-GYP containing
proteins in V. cholerae or whether these proteins have
phosphodiesterase activity.
Herein, we systematically analyze the biochemical and
biological functions of the putative HD-GYP phosphodi-
esterases encoded by V. cholerae. We present in vitro
and in vivo evidence that a subset of the HD-GYP do-
main proteins are enzymatically active and assess the
roles of each HD-GYP domain gene in motility, biofilm
formation and virulence of V. cholerae. This work greatly
furthers the understanding of this important family of
c-di-GMP metabolic enzymes and demonstrates a role
for HD-GYP domain proteins in the virulence of V.
cholerae.
Methods
Bacterial strains and growth conditions V. cholerae
C6706 and isogenic mutant strains (Additional file 1:
Table S1) were cultured in Luria-Bertani (LB) broth con-
taining 100 μg/ml streptomycin (Sm) at 37°C with aer-
ation. Escherichia coli strains were grown in LB broth.
When needed to select for plasmids, 50 μg/ml ampicillin
(Amp) was added to the V. cholerae and E. coli cultures.
DNA manipulations and strain construction
Primers used in the construction of in-frame deletions
of genes encoding putative HD-GYP domain proteins
are listed in Additional file 1: Table S3. Primers for
deletion constructs are labeled with the locus tag of the
target gene followed by F1, R1, F2 or R2 (e.g. VC1087F1
and VC2340R2). Deletions were made using standard
allelic exchange methods [49]. Briefly, regions of hom-
ology upstream and downstream of the gene of interest
were PCR amplified from V. cholerae C6706 genomic
DNA using the geneF1+ geneR1 primers for the upstream
fragment and geneF2 + geneR2 primers for the down-
stream fragment. The primers introduced restriction sites
(Additional file 1: Table S3, underlined) that allowed
cloning of the two PCR products to each other and into
the suicide vector pCVD442. Ligation reaction products
were transformed into DH5α λpir by electroporation,
which were then selected by growth on LB-Amp agar. The
desired clones were identified by screening by PCR with
geneF1 + geneR2 primers and CVDseqF + CVDseqR
primers that flank the multiple cloning site. Plasmids were
purified from confirmed clones and transformed into
Sm10 λpir cells by electroporation. Sm10 λpir strains con-
taining the pCVD442 deletion constructs and V. cholerae
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respectively, then mated on LB agar lacking antibiotics for
6 hours at 37°C. Growth was collected from the agar plate
and streaked onto LB-Sm-Amp agar to select for V.
cholerae transconjugants. Single colonies were grown in
1 mL LB broth lacking antibiotics for 8 hours. Dilutions
were plated onto LB-Sm agar containing 10% sucrose and
incubated for 16 hours at 30°C. Sucrose-resistant,
Amp-sensitive colonies were screened for deletion of
the target gene by PCR using geneF0 and geneR2
primers.
We were unable to inactivate VC2497 by allelic ex-
change, so VC2497 was instead mutated by plasmid
disruption with pGP704. An internal portion of VC2497
was amplified by PCR from V. cholerae C6706 genomic
DNA using primers 2497koF and 2497koR. The product
was digested with BglII and EcoRI and ligated into simi-
larly digested pGP704. Ligation reaction products were
transformed into DH5α λpir cells by electroporation,
followed by selection on LB-Amp agar. Insert-positive
clones were identified by PCR using 2497koF +2497koR.
The resulting pGP704::‘VC2497’ plasmid was introduced
into V. cholerae C6706 by a triparental mating with this
recipient strain, DH5α λpir (pGP704::‘VC2497’), and E.
coli (pRK2013::Tn9). The integration of pGP704 into the
VC2497 locus was confirmed by PCR using 2497koF +
CVDseqR.
For the “ΔHDGYP7” strain, the following genes were
sequentially inactivated as above, in order: VCA0681,
VCA0210, VC2340, VC1348, VCA0895, VC1295, and
VCA0931.
Construction of strains for overexpression
The genes encoding the 9 putative HD-GYP-domain
containing proteins were amplified by PCR from V. cho-
lerae C6706 using the geneF and geneHR primers listed in
Additional file 1: Table S2 (e.g. VC1087F and VC1087HR
primers were used to amplify VC1087). The exception is
VC1295, which was amplified from V. cholerae N16961,
because VC1295 from strain C6706 contains a mutation
encoding a premature stop codon. The geneHR primers
introduce a sequence encoding six histidine residues
at the C-terminus of the translated protein product. The
PCR products for each gene were digested with the re-
striction enzymes indicated in the table and ligated into
pMMB67EH. The ligations were transformed into E. coli
DH5α, with subsequent selection on LB-Amp agar. Clones
were screened using primers geneF + geneHR and primers
67EHF and 67EHR, which flank the multiple cloning site
of pMMB67EH. The correct plasmids were introduced
into E. coli BL21 via electroporation.
To generate a construct for expressing an inactive
allele of VC1348, we replaced the codons for the HD
motif (amino acids 217 and 218) with two codons foralanine. Using C6706 genomic DNA as a template, regions
upstream and downstream of (and including) the targeted
sequence were amplified with primers VC1348F +
VC1348R1-AA and VC1348F2-AA + VC1348HR, respect-
ively. The two fragments, which overlap by 21 nucleotides
including HD to AA mutation, were spliced together
and the full product was amplified by PCR with
primers VC1348F + VC1348HR. The resulting product
was digested with SacI and XbaI, ligated into similarly
digested pMMB67EH, and transformed into E. coli
DH5α. Correct clones were identified by PCR and se-
quencing, yielding pMMB67EH::VC1348AA-His6.
All expression plasmids were introduced into V. cholerae
by conjugation.In vitro c-di-GMP phosphodiesterase assays
Purified His6-WspR protein from Pseudomonas aerugi-
nosa, which contains a catalytically active GGDEF do-
main, was used to synthesize the radiolabelled c-di-GMP
substrate for the phosphodiesterase enzymatic assays
[50]. Purified His6 –WspR (10 μL) was incubated over-
night at 37°C with 5 μL of [α-32P]GTP (3000 Ci/mmol;
PerkinElmer Life Sciences) and 5 μL of 100 mM GTP
buffer containing 75 mM Tris, pH 8, 250 mM NaCl,
25 mM KCl, and 10 mM MgCl2. Subsequent steps were
carried out as described [24].
E. coli BL21 containing either HD-GYP overexpression
plasmid or vector were grown in LB-Amp broth over-
night at 37°C with aeration, then diluted 1:100 in 12 mL
of LB-Amp containing 1 mM IPTG. Cultures were
grown at 30°C until an OD600 of 0.6-0.7 was reached.
Cells were collected by centrifugation at 5000 × g for
10 minutes at 4°C. The cells were suspended in 1 mL of
phosphodiesterase buffer containing 75 mM Tris, pH 8,
25 mM KCl, 25 mM MnCl2, and 10% glycerol. The cells
were lysed by three rounds of freeze-thaw followed by
sonication. Samples were centrifuged at 5,000 × g for
10 minutes at 4°C. Supernatants (soluble material) were
removed and stored at –20°C prior to use in phospho-
diesterase enzymatic assays. Reaction products were
identified based on previously determined migration in
KH2PO4 buffer [51].
Soluble fractions from E. coli BL21 overexpressing
HD-GYP genes were tested for phosphodiesterase activ-
ity by incubating 18 μL of cell lysates with 2 μL of [32P]
c-di-GMP for 0 min to 30 min at room temperature as
previously described [14]. As negative controls, cell ly-
sates from similarly treated E. coli with empty vector
and a buffer-only control were tested. The reactions
were stopped by spotting 0.5 μL of the reactions on PEI-
cellulose and allowing the spots to air-dry. Nucleotides
were separated by thin layer chromatography in 1.5 M
KH2PO4, pH 3.65. PEI-cellulose plates were air-dried.
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using a Storm Phosphorimager (GE Healthcare).
Phenotype assays
Biofilm production was assayed by crystal violet staining
as described previously [52,53]. Briefly, biofilms of V.
cholerae were grown statically in LB broth in 13 mm
diameter glass culture tubes at room temperature (~23°C)
for 24 hours. Where indicated, 1 mM IPTG was added to
induce phosphodiesterase gene expression. Unattached
cells were removed, and the remaining biofilms were
rinsed and stained with 0.1% crystal violet. The stained
biofilms were washed with water, and then the stain was
solubilized with 2 ml of 50% v/v ethanol. The biofilm ma-
terial was dispersed using a sonicating water bath. Biofilm
formation was determined by measuring the absorbance
at 540 nm. At least 3 independent samples were assayed.
Motility was measured using soft agar assays as de-
scribed [54]. Strains were grown overnight at 37°C on
LB +1.5% agar. Single colonies were inoculated into mo-
tility plates (1% tryptone, 0.5% NaCl, 0.3% agar). Where
indicated, 1 mM IPTG was added the plates to induce
phosphodiesterase gene expression. Motility plates were
incubated for 16 hours at 30°C, and colony swarm diam-
eters were measured. Three independent experiments of
at least 4 replicates of each strain were performed.
Western blots
BL21 and V. cholerae strains containing HD-GYP ex-
pression vectors were grown in LB-Amp broth overnight
at 37°C with aeration, then diluted 1:100 in LB-Amp
containing 1 mM IPTG. Cultures were grown at 30°C
with aeration to an OD600 of ~0.7. Cells were collected
by centrifugation at 12,000 × g and suspended in 100 μL
of 2 × Laemmli sample buffer [55]. Samples were sepa-
rated by electrophoresis on a 12% polyacrylamide SDS
gel then transferred to a nitrocellulose membrane. West-
ern blots were carried out according to standard proce-
dures. Primary mouse His-6 antibody (ThermoScientific)
was used at a 1:1000 dilution. Dylight 800 goat α-mouse
secondary antibody (ThermoScientific) was used at a
1:15000 dilution. Blots were imaged using an Odyssey
imager (LI-COR Biosciences).
In vivo competition experiments
The animal experiments were done in accordance with
protocol 12-239 approved by the Institutional Animal
Care and Use Committee at the University of North
Carolina at Chapel Hill. Mouse in vivo competition experi-
ments were carried out in 5 day old CD-1 mice as de-
scribed previously [56]. Briefly, HD-GYP mutant strains
were mixed 1:1 with WT ΔlacZ mice in 0.85% NaCl. To
determine the ratio of mutant to WT in the inocula, these
mixtures were plated on LB-Sm agar containing 40 μg/mL5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal),
which allows differentiation of mutant and ΔlacZ bacteria
(blue versus white colonies, respectively). Mice were inoc-
ulated intragastrically with ~105 total bacteria. Animals
were sacrificed 21 hours post-inoculation. Small intestines
were harvested and homogenized, then dilutions were
plated on LB-Sm agar containing X-Gal. The competition
index was determined by dividing the ratio of mutant/
ΔlacZ bacteria in the homogenates (output) by the ratio of
mutant/ΔlacZ bacteria in the inocula. In parallel, the mix-
tures used to inoculate mice for in vivo competition exper-
iments were also diluted 1:1,000 into 2 ml of fresh LB
broth and incubated overnight to determine the in vitro
competition index. At least 5 mice were used for each com-
petition. Data were analyzed by the Wilcoxon signed-rank
test, with values compared to a hypothetical value of 1.
Results
A subset of the 9 genes of V. cholerae is predicted to
encode enzymatically active HD-GYP domains
V. cholerae N16961 encodes 9 putative HD-GYP domain
c-di-GMP phosphodiesterases with variable lengths, do-
main architectures and predicted cellular localizations.
Most of the proteins are estimated to be approximately
400-500 amino acids in length, though VCA0895 is
considerably larger, with 981 amino acids. Two HD-GYP
domain proteins, VC1295 and VCA0895, have predicted
transmembrane domains and are predicted to be local-
ized in the inner membrane. As is common of c-di-GMP
metabolic enzymes, all 9 HD-GYP domain proteins
contain additional domains potentially involved in regu-
lating protein function. Three HD-GYP domain proteins,
VC1087, VC1348 and VCA0210, possess a phosphore-
ceiver (REC) domain, suggesting that they may be mod-
ulated by phosphorylation. Two of the proteins, VC1295
and VCA0895, contain a domain present in Histidine ki-
nases, Adenylate cyclases, Methyl-accepting proteins
and Phosphatases (HAMP), which is a linker domain
suggested to function in intramolecular signal transduc-
tion [57-59]. Three contain additional domains of un-
known function: VC2497, DUF3391; VCA0210, DUF3369;
and VCA0931, DUF3392. Interestingly, VCA0681 contains
tandem HD and HD-GYP domains. Together, these 9
putative c-di-GMP phosphodiesterases have the potential
to respond to myriad signals to modulate intracellular
c-di-GMP.
Previous studies have used genetic and biochemical ap-
proaches to identify the residues of HD-GYP domain pro-
teins that are important for catalytic activity [21,60-62].
Mutational analysis of PmGH, an HY-GYP domain
phosphodiesterase from Persephonella marina for which
the c-di-GMP cocrystal structure has been solved, identi-
fied at least 11 amino acids required for full phospho-
diesterase activity [60]. Based on conservation of residues
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phosphodiesterase PmGH, four of the 9 putative HD-GYP
domain proteins encoded by V. cholerae are predicted to
be enzymatically active: VC1295, VC1348, VCA0210 and
VCA0931 (Figure 1B). VC2497, VC2340 and VCA0681
(predicted to have tandem HD and HD-GYP domains,
labeled “a” and “b” in Figure 1, respectively) contain one
non-conserved residue required for activity of PmGH.Figure 1 Domain architectures and sequence conservation of putativ
the nine HD-GYP domain proteins encoded by V. cholerae. Shown are HD-G
(green), domains of unknown function (white) and putative transmembran
are indicated. (B) Alignment of V. cholerae HD-GYP domains. The HD-GYP d
tandem domains in VCA0681, were aligned to the HD-GYP domains of Rpf
Omega software. Highlighted are the HD and GYP motifs (yellow), identica
(green). Asterisks indicate residues previously shown to be required for enzTwo, VC1087 and VCA0895, lack an intact HD motif and
are expected to be enzymatically inactive.
Four HD-GYP domain proteins of V. cholerae are
enzymatically active in vivo
To assess the enzymatic activity of each putative HD-
GYP domain phosphodiesterase, we used motility and
biofilm formation, processes well-known to be inhibitede HD-GYP domain proteins of V. cholerae. (A) Predicted domains of
YP domains (blue), phosphoreceiver domains (red), HAMP domains
e domains (black). The lengths of the proteins (number of amino acids)
omain amino acid sequences from V. cholerae, including the two
G from X. campestris and PmGH from Persephonella marina using Clustal
l amino acid residues (orange) and conserved amino acid residues
ymatic activity of PmGH [61].
Figure 2 Ectopic over-expression of HD-GYP genes in V.
cholerae. Each gene encoding a putative HD-GYP domain protein,
tagged with a 6-histidine sequence at the 3′ end, was expressed
ectopically in V. cholerae using an IPTG-inducible promoter. (A)
Production of each protein in V. cholerae after ~3 hours growth in
the presence of 1 mM IPTG was assessed by western blot using
anti-His6 antibodies. The predicted molecular weights of each protein,
in kDa, are indicated at the bottom. Right: Expression of the large,
predicted membrane protein VCA0895 was relatively poor; detection of
the recombinant protein required loading more sample. (B) Motility of
V. cholerae expressing each of the HD-GYP domain genes was assayed
in soft agar medium as an indication of c-di-GMP hydrolysis, which
augments flagellar motility of V. cholerae. Each strain was inoculated
into motility medium with (grey bars) or without (white bars) 0.5 mM
IPTG. The diameter of each motility swarm was measured after 20
hours incubation at room temperature. Shown are means and standard
deviations for three biological replicates. (C) Biofilm formation by V.
cholerae expressing each of the HD-GYP domain encoding genes was
assessed as an indication of c-di-GMP hydrolysis, which decreases
biofilm formation by V. cholerae. Each strain was grown in LB broth
with (grey bars) or without (white bars) 0.5 mM IPTG to induce gene
expression. Biofilm was assayed using standard crystal violet methods.
Shown are means and standard deviations for three biological replicates.
*P <0.05 by two-way ANOVA with Bonferroni’s post-test.
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as phenotypic indicators of in vivo enzymatic activity
[14,40,43,63]. Each HD-GYP domain-encoding gene was
ectopically expressed in V. cholerae under the regulation
of an inducible promoter. We used alleles containing a
C-terminal sequence encoding a 6-histidine tag, allowing
us to confirm expression by western blot. Each strain
produced a His6-tagged protein of approximately the an-
ticipated molecular weight, though the abundance of the
proteins varied (Figure 2A, left). Expression of VCA0895-
His6 was relatively poor; visualization required loading
twice the amount of sample and a longer exposure of the
membrane (Figure 2A, right).
The strains were then assayed for altered motility and
biofilm formation compared to the parental strain carry-
ing vector only, each with and without IPTG to induce
gene expression. V. cholerae expressing the characterized
EAL domain phosphodiesterase VC1592 was included as
a positive control for both experiments [46]. Expression
of VC1592, VC1295, VC1348, VCA0210, and VCA0681
significantly increased motility of V. cholerae through
0.3% agar medium, as evinced by expanded diameters of
motility (Figure 2B). Expression of the same genes sig-
nificantly decreased biofilm formation in rich medium
on glass (Figure 2C). These results are consistent with
reduced intracellular c-di-GMP upon expression of
c-di-GMP phosphodiesterases and suggest that VC1295,
VC1348, VCA0210 and VCA0681 encode active HD-
GYP domain c-di-GMP phosphodiesterases. As ex-
pected, VC1087 and VCA0895, which lack an intact HD
motif, had no effects on motility or biofilm formation.
A subset of HD-GYP domain proteins of V. cholerae are
enzymatically active in vitro
Because the HD-GYP domain proteins could affect
biofilm formation and swimming motility independently
of c-di-GMP hydrolytic activity, we also assayed their
enzymatic activity in vitro. The same plasmids used for
expression in V. cholerae were transformed into E. coli
BL21. These strains were grown in the presence of IPTG
to induce gene expression; E. coli BL21 with vector only
was included as a negative control. Production of His6-
tagged HD-GYP domain proteins was confirmed by
western blot (Figure 3A, left). As in V. cholerae, E. coli
expressing VCA0895 produced less protein, and loading
2-fold more sample was needed to detect VCA0895-
His6 (Figure 3A, right). Culture lysates were tested for
the ability to hydrolyze c-di-GMP by incubating them
with radiolabeled c-di-GMP. The reaction products were
separated by TLC and visualized by phosphorimagery. In
vitro, VC1295, VCA0210 and VCA0681 reproducibly hy-
drolyzed c-di-GMP (Rf ~0.3) at levels above that of the
vector-only negative control. Notably, in these reactions,
both linearized pGpG (Rf ~0.55) and GMP (Rf ~0.65)
Figure 3 Heterologous expression of HD-GYP genes in E. coli. Each gene encoding a putative HD-GYP domain protein, tagged with a
6-histidine sequence at the 3′ end, was expressed ectopically in E. coli BL21. (A) Production of each protein after ~3 hours growth in the presence
of 1 mM IPTG was assessed by western blot using anti-His6 antibodies. The predicted molecular weights of each protein, in kDa, are indicated
at the bottom. Right: Expression of the large, predicted membrane protein VCA0895 was relatively poor; detection of the recombinant protein
required loading more sample. (B) Lysates of E. coli BL21 expressing each of the HD-GYP domain-encoding genes were tested for the ability to
hydrolyze c-di-GMP as described in the Methods. Buffer only (“B”) and lysates from E. coli BL21 with vector only were included as negative controls. The
radiolabeled c-di-GMP substrate has a relative mobility (Rf) of ~0.3 and appears for all samples at t =0, when the reaction was initiated by addition of
[32P]-c-di-GMP. The GMP reaction product appears at Rf ~0.65.
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failed to hydrolyze c-di-GMP above background levels.
VC1087 and VCA0895, as expected, were inactive.
The effect of VC1348 expression on swimming motility
require(s) c-di-GMP phosphodiesterase activity
For eight of the nine HD-GYP domain proteins, the
in vivo over-expression and in vitro enzymatic assays were
in agreement, indicating that VC1295, VCA0210 and
VCA0681 are functional c-di-GMP phosphodiesterases.
Expression of the remaining HD-GYP domain protein,
VC1348, increased motility and decreased biofilm forma-
tion of V. cholerae, consistent with reduced c-di-GMP in
this strain. However, no c-di-GMP phosphodiesterase
activity could be detected in vitro. To determine if thephenotypic changes upon VC1348 expression in V. cholerae
were due to phosphodiesterase activity, the effect of
expressing a mutant allele of VC1348 on V. cholerae
motility was assessed as described above. The result-
ing mutant protein, herein named VC1348AA, con-
tains alanine substitutions in the HD motif (amino
acids 217 and 218), which has been shown to be re-
quired for c-di-GMP phosphodiesterase activity [21].
Expression of the positive control gene VC1592 and
wild type VC1348 significantly increased motility of
V. cholerae through 0.3% agar, while expression of
VC1348AA did not (Figure 4). These results indicate
that the HD motif of VC1348, and therefore c-di-GMP
hydrolysis by this protein, is required for function
in vivo.
Figure 4 The HD residues of VC1348 are required for in vivo
function. The genes encoding wild type VC1348 and VC1348 with
alanine substitutions in the HD motif (VC1348AA) were expressed
ectopically in V. cholerae using an IPTG-inducible promoter. The EAL
domain PDE VC1592 was included as a positive control. The motility
of V. cholerae bearing expression plasmids or vector control was
assayed in soft agar medium as an indication of c-di-GMP hydrolysis,
which augments flagellar motility of V. cholerae. Each strain was
inoculated into motility medium with (grey bars) or without (white bars)
0.5 mM IPTG. The diameter of each motility swarm was measured after
20 hours incubation at room temperature. Shown are the means and
standard deviations for six biological replicates. ***P <0.001 by two-way
ANOVA with Bonferroni’s post-test.
Figure 5 Abundance of mRNA encoding HD-GYP domain
proteins in V. Cholerae biofilms. qRT-PCR was used to measure
the transcript abundance for each HD-GYP mRNA, the reference
housekeeping gene rpoB, and the biofilm-induced control gene vpsT.
The relative differences in transcript abundance between biofilm
and planktonic V. cholerae cells were determined as described in
the Methods. *P <0.05 by unpaired t-test comparing biofilm to
planktonic values, indicating a significant change in transcript
abundance in biofilm relative to planktonic cells.
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during planktonic and biofilm growth
We postulated that the expression of the HD-GYP
domain-encoding genes may be differentially expressed
during growth of V. cholerae in a biofilm compared to
in planktonic culture. For instance, one or more of the
genes might be down-regulated, leading to increased
intracellular c-di-GMP and enhanced biofilm forma-
tion. To get a picture of the transcriptional profiles of
the HD-GYP domain genes, we used qRT-PCR to
determine the relative expression of each HD-GYP
domain gene in biofilm and planktonic culture. The vpsT
gene, previously determined to be upregulated in a
biofilm, was included as a positive control [64]. Several
transcripts, VC1348, VCA0210, VCA0681, and VCA0895,
were significantly more abundant in biofilm cells than in
planktonic cells (Figure 5). Only one, VC2497, was signifi-
cantly reduced in biofilms. These data suggest that c-di-
GMP phosphodiesterases can be upregulated in biofilms,
for example to counter the activities of diguanylate cy-
clases during biofilm development.Analysis of the roles of HD-GYP domain phosphodiesterases
in motility, biofilm and virulence of V. cholerae
To assess the functions of the HD-GYP domain phos-
phodiesterases in V. cholerae, in-frame deletions were
made in each gene, and the mutants were tested for al-
tered biofilm formation and motility. None of the mutants
showed phenotypes different from the WT parental strain
(Figure 6A and C). To address the possibility that two or
more of the HD-GYP proteins have redundant functions,
additional mutants were made in which multiple HD-GYP
encoding genes were deleted. None of these mutants,
including strain ΔHDGYP7 (ΔVCA0681 ΔVCA0210
ΔVC2340 ΔVC1348 ΔVCA0895 ΔVC1295 and ΔVCA
0931), which contains mutations in all HD-GYP genes
encoding functional enzymes, were phenotypically dif-
ferent from the WT parent (Figure 6B and D).
Previous work with the infant mouse model has shown
that c-di-GMP inhibits the ability of V. cholerae to ef-
fectively colonize the intestine. Mutation of the EAL
domain phosphodiesterase VieA reduced fitness of V.
cholerae O395 in the infant mouse [15]. We thus tested
each of the HD-GYP mutants for colonization of the in-
fant mouse small intestine using a competition assay. In
this study, equivalent numbers of differentially labeled
WT (lacZ+) and mutant (ΔlacZ) bacteria were co-
inoculated into infant mice. After 21 hours, the small in-
testines were harvested, homogenized and plated on
media containing X-gal to enumerate the WT and mu-
tant bacteria. Competition indices were determined by
Figure 6 Biofilm and motility phenotypes of V. cholerae strains containing mutations in one or more HD-GYP domain encoding genes.
V. cholerae containing mutations in single (A) or multiple (B) HD-GYP genes were assayed for biofilm formation after 48 hours static growth in
rich medium using crystal violet staining. A vpsR mutant was included as a negative control. Shown are the means and standard deviations for
three biological replicates. V. cholerae containing mutations in single (C) or multiple (D) HD-GYP genes were assayed for motility in soft agar
medium. A flaA mutant was included as a negative control. Swarm diameters were measured after 20 hours growth at room temperature.
Shown are the means and standard deviations for three biological replicates.
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to the ratio of mutant: WT bacteria in the input mix-
tures. None of the individual HD-GYP gene mutations
affected the ability of V. cholerae to colonize the infant
mouse small intestine (Figure 7). Interestingly, the addi-
tive mutation of 7 HD-GYP domain genes (ΔHD-GYP7),
including all those that are enzymatically active PDEs,
led to a significant decrease in bacterial burden in the
small intestine (mean CI = 0.135, P <0.001). This may be
attributable in part to overall reduced fitness of the mutant,
as the ΔHD-GYP7 strain was slightly attenuated for growth
in LB compared to the ΔlacZ control (mean CI = 0.639,
P <0.05). These results indicate that two or more HD-GYP
genes in combination are important for virulence of V.
cholerae. Alternatively, the cumulative effects of multiplePDE on intracellular c-di-GMP levels during infection may
impair host colonization.
Discussion
The c-di-GMP signaling system of V. cholerae is com-
plex, including a large number of c-di-GMP synthases,
hydrolases, effectors and regulatory targets. This work
presents a methodical analysis of the functions of all 9
HD-GYP domain proteins encoded by V. cholerae.
Using in vitro and in vivo approaches, we found that a
subset of the HD-GYP domain proteins possesses c-di-
GMP phosphodiesterase activity. Activity correlates well
with conservation of residues previously determined to
be required for activity and with the overall consensus
sequence of the HD-GYP domain [61,65]. We expected
Figure 7 Assessment of virulence phenotypes V. cholerae
HD-GYP gene mutants using the infant mouse model.
Competition experiments were performed using the infant mouse
model. Each mutant was co- inoculated in equal numbers with V.
cholerae ΔlacZ (1:1 ratio) into 5-day-old CD1 mice. The bacteria
present in the small intestine after 21 hours were enumerated on LB
agar plates containing X-gal to differentiate mutant bacteria (blue
colonies) from ΔlacZ bacteria (white colonies). The competition
index (CI) was calculated as [(mutant CFU/ΔlacZ CFU)output]/[(mutant
CFU/ΔlacZ CFU)input]. Each circle represents the CI from an individual
animal, and the bars indicate the median. At least 4 mice were used
per competition. ***P <0.001, one sample t-test comparing values to
a hypothetical value of 1 (i.e., no difference between mutant and
wild-type) and by one-way ANOVA.
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be enzymatically active proteins; each contains con-
served residues previously shown to be required for
activity of PmGH [61]. In addition, each contains con-
served residues in the GYP motif region and other resi-
dues involved in recognition of c-di-GMP [61,66]. We
consistently observed in vivo and in vitro activity for
VC1295 and VCA0210. VC1348 caused increased motil-
ity and reduced biofilm formation when expressed in V.
cholerae, suggesting that it is able to hydrolyze c-di-
GMP in vivo, but we did not detect enzymatic activity
in vitro. Mutating the HD residues required for
phosphodiesterase activity of HD-GYP domain proteins
ablated the effect of VC1348 expression on motility of V.
cholerae. These results indicate that VC1348 is indeed a
functional c-di-GMP phosphodiesterase in V. cholerae.
We suspect that expression of VC1348 in V. cholerae al-
lows VC1348 to be post-translationally activated, likely
though its REC domain, but that the activating partner
is absent in E. coli BL21. The adjacent, divergently
transcribed gene VC1349 encodes a putative sensor kin-
ase/response regulator and may regulate VC1348 in V.
cholerae. VCA0931 failed to demonstrate c-di-GMP hy-
drolysis, neither affecting biofilm formation or motility.19pt]?>of V. cholerae nor hydrolyzing c-di-GMP in vitro.
VCA0931 possesses an N-terminal domain of unknown
function, which may post-translationally regulate the HD-
GYP domain in response to specific cues lacking in our
assays, or mask activity of the HD-GYP domain [33].
As we anticipated, VC1087 and VCA0895, which
lack the HD dyad characteristic of HD metal-dependent
phosphohydrolases, showed no evidence of c-di-GMP
hydrolytic activity in vivo and in vitro. The activities of a
subset of the HD-GYP domain proteins could not be
easily predicted due to lack of conservation of one or
more residues expected to be required for activity:
VC2497, VC2340 and VCA0681 [21,61]. While VC2497
and VC2340 were inactive in all assays used, VCA0681
consistently showed phosphodiesterase activity. VCA0681
is one of the few HD-GYP proteins studied to date. Its
enzymatic activity was previously demonstrated and its
crystal structure was solved [47,60]. The differences be-
tween the inactive VC2497 and VC2340 and the active
HD-GYP domain proteins that determine enzymatic func-
tionality are not readily apparent. Indeed, VCA0681 is a
functional PDE despite lacking an aspartic acid required
for activity of PmGH (D308 in PmGH, Q373 in
VCA0681). The substitution of an aspartic acid with an
asparagine in VCA0681 may preserve enzymatic activ-
ity, or the requirements of PmGH may not be universal
to all HD-GYP domain PDEs. Further characterization
of structure-function relationships of HD-GYP domain
phosphodiesterases from a variety of organisms will be
necessary to define the features required for activity.
Analysis of the expression of the HD-GYP domain genes
in V. cholerae showed that VC1348, VCA0210, VCA0681
and VCA0895 transcripts are significantly higher in
biofilm-derived V. cholerae than in planktonic cells.
Interestingly, three of these genes, VCA0210, VCA0681
and VCA0895 were among the four HD-GYP domain
genes regulated by quorum sensing [47]. Thus, high cell
density in the V. cholerae biofilm may be the signal con-
trolling expression of these genes.
We found that mutation of individual HD-GYP domain
genes did not affect c-di-GMP regulated phenotypes of V.
cholerae under the conditions tested. Even removal of all
active (and many inactive) HD-GYP domain proteins in a
single strain had no effect on motility or biofilm produc-
tion. There are several possible reasons for the lack of
phenotypic differences from the parent strain. First, it re-
mains possible that HD-GYP domain phosphodiesterases,
individually or as a class, impact c-di-GMP regulated pro-
cesses other than those investigated here. Second, not all
HD-GYP domain proteins are likely to be produced or
enzymatically active under the conditions tested, so elim-
inating them may not have an observable effect. Our qRT-
PCR studies of HD-GYP gene expression in planktonic
and biofilm cultures support this possibility—expression
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conditions. The observation that a VC1295 mutant
produces somewhat more biofilm in the presence of
bile acids further indicate that specific extracellular
cues may be necessary to stimulate HD-GYP produc-
tion and/or activity [48].
There may also be strain-dependent differences in the
panel of c-di-GMP metabolic enzymes used, and differ-
ent results might be obtained using a different V. cho-
lerae strain. For example, mutation of the EAL domain
phosphodiesterase VieA in the classical biotype of V.
cholerae (strain O395) causes marked effects on motility,
biofilm formation and virulence gene expression [15,40];
the same mutation in the El Tor strain C6709 has no ef-
fect on these processes [14,47].
HD-GYP domain proteins can also perform their
regulatory function via physical interactions with other
proteins, independently of c-di-GMP phosphodiesterase
activity. In Xanthomonas spp., for example, the HD-GYP
phosphodiesterase RpfG interacts with two diguanylate
cyclases to regulate motility [21,66,67]. The HD-GYP
domain protein ECA3548 from Pectobacterium atrosep-
ticum lacks apparent c-di-GMP phosphodiesterase activ-
ity (and lacks the conserved HD motif ), yet still impacts
c-di-GMP regulated processes, possibly via direct inter-
actions with other proteins [68]. The HD-GYP domain
proteins of V. cholerae may also rely on protein-protein
interactions to mediate their effects, and the necessary
interactions may not have been achieved through over-
expression or mutagenesis.
Finally, there is potential for phenotypic redundancy
among the HD-GYP domain phosphodiesterases, as well
as with EAL domain phosphodiesterases. Upon mutation
of each of the GGDEF and EAL domain genes in V. cho-
lerae, and only some mutants showed altered motility
and/or biofilm development [41,45]. Therefore the chance
of observing an effect of mutating the HD-GYP subset of
c-di-GMP phosphodiesterases may be low. This is sup-
ported by our finding that individually, mutation of HD-
GYP genes had no effect on the ability of V. cholerae to
colonize the infant mouse small intestine, but a combin-
ation of mutations (ΔHDGYP7) significantly impaired
colonization. It is possible that a combination of two or
more HD-GYP domain proteins, or that the additive ef-
fects of multiple c-di-GMP PDEs, influence virulence of
V. cholerae. These findings suggest that HD-GYP domain
proteins as a family influence c-di-GMP levels during
infection, which has previously been shown to impact V.
cholerae virulence by regulating the virulence gene regula-
tor ToxT [14,15].
In the context of an infection, discrete extracellular
signals may trigger the production or activity of a
specific c-di-GMP phosphodiesterase (or diguanylate cy-
clase), with cumulative but targeted effects on virulencegene expression. Strictly speaking, the c-di-GMP phos-
phodiesterases involved would not be mechanistically re-
dundant (for example, having different interacting
partners or subcellular localization), but work together
toward the same phenotypic output. Such a regulatory
system may allow V. cholerae to induce virulence gene
expression in the host despite the absence or mitigation
of one specific extracellular signal. A different set of c-
di-GMP metabolic enzymes could modulate biofilm or
motility in response to a distinct set of signals.
Conclusions
Compared to GGDEF domain diguanylate cyclases and
EAL domain phosphodiesterases, the HD-GYP domain
phosphodiesterases have been understudied. This may
be partly due to the fact that genes encoding HD-GYP
domains are less widespread in bacterial genomes than
those encoding GGDEF and EAL domains [38,65]. In V.
cholerae, only a subset of the HD-GYP domain genes
encoded are functional c-di-GMP PDEs. The individual
HD-GYP domain genes are dispensable for motility and
biofilm formation under the conditions tested, but col-
lectively two or more of the genes are important for
virulence of V. cholerae. Additional studies of HD-GYP
domain proteins from other bacteria are needed to gain
a full understanding their roles in c-di-GMP signaling.
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